SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Analyst Earnings Estimates
FRA:1SXP - Deutsche Boerse Ag - DE000A3ENQ51 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 821.1M 26.58% | 898.602M 9.44% | 957.091M 6.51% | 1.043B 8.98% | 1.167B 11.89% | 1.286B 10.20% | 1.41B 9.64% | 1.584B 12.34% | 2.014B 27.15% | 2.074B 2.98% | |
| EBITDA YoY % growth | 223.5M 47.72% | 217.822M -2.54% | 255.565M 17.33% | 297.47M 16.40% | 361.6M 21.56% | 413.87M 14.46% | 437.8M 5.78% | 496.64M 13.44% | 562.43M 13.25% | 604.82M 7.54% | |
| EBIT YoY % growth | 168.1M 46.30% | 171.174M 1.83% | 190.587M 11.34% | 207.76M 9.01% | 255.44M 22.95% | 293.47M 14.89% | 335.58M 14.35% | 368.7M 9.87% | N/A | N/A | |
| Operating Margin | 20.47% | 19.05% | 19.91% | 19.92% | 21.89% | 22.82% | 23.80% | 23.28% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | 0.99 4.50% | 1.06 6.64% | 1.29 21.74% | 1.48 14.87% | 1.77 19.69% | 1.93 9.45% | N/A | N/A |
All data in EUR
| Q2 / 25 | Q3 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 0.25 47.90% | 0.29 -5.40% |
| Revenue Q2Q % growth | 252.62M 8.07% | 282.71M 11.48% |
| EBITDA Q2Q % growth | 67.485M 20.61% | 78.07M -23.02% |
| EBIT Q2Q % growth | 49.51M 94.32% | 58.263M 7.02% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -16.82% | 0.24 | % | |
| Q4 2024 Q2Q % growth | 0.22 -4.35% | 0.25 | -0.03 | -10.99% |
| Q3 2024 Q2Q % growth | 0.31 | 0.21 | 0.10 | 50.83% |
| Q2 2024 Q2Q % growth | 0.17 | 0.21 | -0.04 | -20.63% |
| Q1 2024 Q2Q % growth | 0.29 | 0.28 | 0.01 | 3.11% |
| Q4 2023 Q2Q % growth | 0.23 | 0.16 | 0.07 | 40.93% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 229.841M -1.04% | 247.83M | -17.989M | -7.26% |
| Q4 2024 Q2Q % growth | 237.051M 3.73% | 244.39M | -7.339M | -3.00% |
| Q3 2024 Q2Q % growth | 253.587M -62.16% | 228.25M | 25.337M | 11.10% |
| Q2 2024 Q2Q % growth | 233.749M | 238.89M | -5.141M | -2.15% |
| Q1 2024 Q2Q % growth | 232.251M | 212M | 20.251M | 9.55% |
| Q4 2023 Q2Q % growth | 228.516M 12.57% | 233.12M | -4.604M | -1.97% |
| Q3 2023 Q2Q % growth | 670.086M 8.41% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -12.9% | -3.5% | -6.57% |
| Revenue | 0% | -4.98% | -1.7% | -3.69% |